Vaccine Adjuvants Preparation Methods and Research Protocols /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2000.
|
| Edición: | 1st ed. 2000. |
| Colección: | Methods in Molecular Medicine,
42 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1385/1592590837 |
Tabla de Contenidos:
- An Overview of Adjuvant Use
- Harmful and Beneficial Activities of Immunological Adjuvants
- Freund's Adjuvants
- Aluminum Compounds as Vaccine Adjuvants
- Poly(Lactide-Coglycolide) Microparticles As Vaccine Adjuvants
- Poly(Methyl Methacrylate) Nanoparticles As Vaccine Adjuvants
- Aqueous Formulation of Adjuvant-Active Nonionic Block Copolymers
- Liposomes As Immunological Adjuvants and Vaccine Carriers
- Immunopotentiating Reconstituted Influenza Virosomes (IRIVs)
- Cochleates for Induction of Mucosal and Systemic Immune Responses
- Virus-like Particles As Vaccine Adjuvants
- The Adjuvant MF59: A 10-Year Perspective Gary Ott, Ramachandran Radhakrishnan,
- Preparation of the Syntex Adjuvant Formulation (SAF, SAF-m, and SAF-1)
- The ISCOM™ Technology
- QS-21 Adjuvant
- MPL® Immunostimulant: Adjuvant Formulations
- Cytokines As Vaccine Adjuvants: The Use of Interleukin-2
- DNA As an Adjuvant
- Transcutaneous Immunization
- Mutant Heat-Labile Entertoxins As Adjuvants for CTL Induction.